Department of Biomedical Sciences | The Graduate School Kyungpook National University | South Korea
🌟 Yoon-Jung Choi is a distinguished microbiologist from Daegu, Republic of Korea. With extensive experience in microbiology and food science, Yoon-Jung is currently a postdoctoral researcher at Kyungpook National University’s School of Medicine.
Profile
ORCID
Education
- Postdoctoral Researcher in Microbiology (Mar 2024 – Present), Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
- Ph.D. in Microbiology (Mar 2020 – Feb 2024), Department of Microbiology, School of Biomedical Science, Kyungpook National University, Daegu, Republic of Korea.
- Thesis: “Bacteriophage-Based Approaches to Combat Acinetobacter baumannii Infections.”
- M.S. in Food Microbiology (Mar 2010 – Feb 2012), School of Food Science and Biotechnology, Kyungpook National University, Daegu, Republic of Korea.
- B.S. in Food Engineering and Food and Nutrition (Mar 2006 – Feb 2010), School of Food Science and Biotechnology, Daegu National University, Daegu, Republic of Korea.
Experience
- Researcher at NiKom (Apr 2019 – Nov 2019), Gyeongbuk Agricultural Research and Extension Services (Oct 2018 – Mar 2019), Cosmetic Molecular Cell Biology Laboratory (Dec 2017 – May 2018), Gyeongbuk Agricultural Research and Extension Services (Aug 2014 – Dec 2015), MEDIOGEN CO. (Dec 2011 – Apr 2014).
Research Interests
- Bacteriophage therapy and antimicrobial peptides.
- Antibiotic resistance mechanisms in clinical pathogens.
- Fermentation technology and food microbiology.
- Detection methods for pathogenic bacteria using phage endolysins.
Awards
- Best Poster Award in Chemistry & Food Science Session, Shizuoka University Japan (2011).
Publications
- 2024 – CHAPSAP26-161, a truncated protein and enzymatic active domain of endolysin LysSAP26, as a potential therapeutic agent to combat Clostridioides difficile infection. Journal of Bacteriology and Virology. Cited by: 10 articles
- 2024 – A novel truncated CHAP modular endolysin, CHAPSAP26-161, that lyses Staphylococcus aureus, Acinetobacter baumannii, and Clostridioides difficile, and exhibits therapeutic effects in a mouse model of Acinetobacter baumannii infection. Journal of Microbiol Biotechnol. Cited by: 15 articles
- 2023 – Development of a Magnetic Bead-Based Method for Specific Detection of Enterococcus faecalis Using C-Terminal Domain of ECP3 Phage Endolysin. Journal of Microbiol Biotechnol. Cited by: 8 articles
- 2023 – Differentiation of Escherichia fergusonii and Escherichia coli Isolated from Patients with Inflammatory Bowel Disease/Ischemic Colitis and Their Antimicrobial Susceptibility Patterns. Antibiotics. Cited by: 12 articles
- 2021 – Antibacterial Effects of Recombinant Endolysins in Disinfecting Medical Equipment: A Pilot Study. Frontiers in Microbiology. Cited by: 20 articles
- 2020 – LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity. Viruses. Cited by: 25 articles